Leukemia & Lymphoma, 1029-2403

Journal

More filtering options
  1. Article
  2. Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML

    Delsing Malmberg, E., Johansson Alm, S., Nicklasson, M., Lazarevic, V., Ståhlman, S., Samuelsson, T., Lenhoff, S., Asp, J., Mats Ehinger, Palmqvist, L., Brune, M. & Fogelstrand, L., 2019, In : Leukemia and Lymphoma. 60, 2, p. 409-417

    Research output: Contribution to journalArticle

  3. Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations

    Dreyling, M., Aurer, I., Cortelazzo, S., Hermine, O., Hess, G., Mats Jerkeman, Le Gouill, S., Ribrag, V., Trněný, M., Visco, C., Walewski, J., Zaja, F. & Zinzani, P. L., 2018, In : Leukemia and Lymphoma. 59, 8, p. 1814-1828

    Research output: Contribution to journalArticle

  4. Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study

    Henrik Cederleuf, Hjort Jakobsen, L., Fredrik Ellin, de Nully Brown, P., Stauffer Larsen, T., Bøgsted, M., Relander, T., Mats Jerkeman & El-Galaly, T. C., 2017 Dec 2, In : Leukemia and Lymphoma. 58, 12, p. 2815-2823 9 p.

    Research output: Contribution to journalArticle

  5. Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker

    Hasni, M. S., Berglund, M., Yakimchuk, K., Guan, J., Linderoth, J., Amini, R-M., Enblad, G. & Okret, S., 2017 Feb 1, In : Leukemia & Lymphoma. 58, 2, p. 418-427 10 p.

    Research output: Contribution to journalArticle

  6. Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia

    Yektaei-Karin, E., Zovko, A., Nilsson, A., Näsman-Glaser, B., Kanter, L., Rådmark, O., Wallvik, J., Marja Ekblom, Dolinska, M., Qian, H. & Stenke, L., 2017, In : Leukemia & Lymphoma. 58, 8, p. 1903-1913 11 p.

    Research output: Contribution to journalArticle

  7. Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

    Hess, G., Rule, S., Jurczak, W., Mats Jerkeman, Santucci Silva, R., Rusconi, C., Caballero, D., Joao, C., Witzens-Harig, M., Bence-Bruckler, I., Cho, S-G., Zhou, W., Goldberg, J. D., Trambitas, C., Enny, C., Vermeulen, J., Traina, S., Chiou, C. F., Diels, J. & Dreyling, M., 2017, In : Leukemia and Lymphoma. 58, 12, p. 2824-2832

    Research output: Contribution to journalArticle

  8. SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.

    Venera Kuci, Nordström, L., Conrotto, P. & Sara Ek, 2016, In : Leukemia & Lymphoma.

    Research output: Contribution to journalArticle

  9. Single nucleotide polymorphism array analysis of clonal evolution in younger adult acute lymphoblastic leukemia

    Dirse, V., Gineikiene, E., Zvirblis, T., Bertasiute, R., Kajsa Paulsson & Griskevicius, L., 2016, In : Leukemia & Lymphoma. 57, 11, p. 2716-2719 4 p.

    Research output: Contribution to journalArticle

  10. Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia

    Ivanov Öfverholm, I., Tran, A. N., Linda Olsson, Zachariadis, V., Heyman, M., Rudd, E., Syk Lundberg, E., Nordenskjöld, M., Bertil Johansson, Nordgren, A. & Barbany, G., 2016, In : Leukemia & Lymphoma. 57, 9, p. 2161-2170 10 p.

    Research output: Contribution to journalArticle

  11. F-18-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study

    Mylam, K. J., Kostakoglu, L., Hutchings, M., Coleman, M., Lamonica, D., Czuczman, M. S., Diehl, L. F., Nielsen, A. L., Jensen, P., Loft, A., Hendel, H. W., Iyer, V., Leppa, S., Jyrkkio, S., Holte, H., Eriksson, M., Gillstrom, D., Hansen, P. B., Seppanen, M., Hjorthaug, K. & 2 othersBrown, P. D. N. & Pedersen, L. M., 2015, In : Leukemia & Lymphoma. 56, 7, p. 2005-2012

    Research output: Contribution to journalArticle

  12. Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib

    Ohm, L., Lundqvist, A., Dickman, P., Hoglund, M., Persson, U., Stenke, L., Carlsson, K. S. & Bjorkholm, M., 2015, In : Leukemia & Lymphoma. 56, 5, p. 1385-1391

    Research output: Contribution to journalArticle

  13. Joint occurrence of Merkel cell carcinoma and non-Hodgkin lymphomas in four Nordic countries

    Koljonen, V., Rantanen, M., Sahi, H., Mellemkjaer, L., Hansen, B. T., Chen, T., Kari Hemminki & Pukkala, E., 2015, In : Leukemia & Lymphoma. 56, 12, p. 3315-3319

    Research output: Contribution to journalArticle

  14. Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas

    Högfeldt, T., Johnsson, P., Grandér, D., Bahnassy, A. A., Anna Porwit, Eid, S., Österborg, A., Zekri, A. R. N., Lundahl, J., Khaled, M. H., Mellstedt, H. & Moshfegh, A., 2014 Jan 1, In : Leukemia and Lymphoma. 55, 5, p. 1158-1165

    Research output: Contribution to journalArticle

  15. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic

    Mulligan, S. P., Karlsson, K., Stromberg, M., Jonsson, V., Gill, D., Hammerstrom, J., Hertzberg, M., McLennan, R., Uggla, B., Norman, J., Wallvik, J., Sundstrom, G., Johansson, H., Brandberg, Y., Liliemark, J. & Gunnar Juliusson, 2014, In : Leukemia & Lymphoma. 55, 12, p. 2769-2777

    Research output: Contribution to journalArticle

  16. Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

    Machaczka, M., Johansson, J-E., Remberger, M., Hallbook, H., Malm, C., Lazarevic, V., Wahlin, A., Omar, H., Gunnar Juliusson, Kimby, E. & Hagglund, H., 2012, In : Leukemia & Lymphoma. 53, 9, p. 1699-1705

    Research output: Contribution to journalArticle

  17. Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry.

    Abrahamsson, A., Dahle, N. & Mats Jerkeman, 2011, In : Leukemia & Lymphoma. 52, 10, p. 1929-1935

    Research output: Contribution to journalArticle

  18. Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study.

    Tove Wästerlid, Jonsson, B., Hagberg, H. & Mats Jerkeman, 2011, In : Leukemia & Lymphoma. 52, 11, p. 2090-2096

    Research output: Contribution to journalArticle

  19. Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden.

    Lj Lazarevic, V., H X00e4 Gglund, H., Remberger, M., Wahlin, A., Hallb X00f6 X00f6 K, H., Gunnar Juliusson, Kimby, E., Malm, C., Omar, H. & Johansson, J-E., 2011, In : Leukemia & Lymphoma. 52, p. 69-71

    Research output: Contribution to journalArticle

  20. 'Hairy' cells: where are the roots of this leukemia?

    Gunnar Juliusson, Tadmor, T. & Polliack, A., 2011, In : Leukemia & Lymphoma. 52, p. 2205-2206

    Research output: Contribution to journalArticle

  21. Hairy cell leukemia: epidemiology, pharmacokinetics of cladribine, and long-term follow-up of subcutaneous therapy.

    Gunnar Juliusson & Samuelsson, H., 2011, In : Leukemia & Lymphoma. 52 Suppl 2, p. 46-49

    Research output: Contribution to journalArticle

  22. CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

    Fjordén, K., Linderoth, J., Nyman, H., Mats Ehinger, Joost, P., Pär-Ola Bendahl, Leppä, S. & Mats Jerkeman, 2010, In : Leukemia & Lymphoma. 51, p. 1643-1648

    Research output: Contribution to journalArticle

  23. Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention.

    Stolz, C. & Schuler, M., 2009, In : Leukemia & Lymphoma. 50, p. 873-885

    Research output: Contribution to journalArticle

  24. Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia

    Lazarevic, V. L., Liljeholm, M., Forsberg, K., Söderberg, S. & Wahlin, A., 2008 Jun, In : Leukemia & Lymphoma. 49, 6, p. 1209-11 3 p.

    Research output: Contribution to journalArticle

  25. Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: A randomized phase II study from the Nordic Lymphoma Group

    Kimby, E., Jurlander, J., Geisler, C., Hagberg, H., Holte, H., Lehtinen, T., Östenstad, B., Hansen, M., Österborg, A., Lindén, O. & Sundström, C., 2008, In : Leukemia & Lymphoma. 49, 1, p. 102-112

    Research output: Contribution to journalArticle

  26. Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: Higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN

    Fridberg, M., Servin, A., Anagnostaki, L., Linderoth, J., Berglund, M., Soderberg, O., Enblad, G., Rosen, A., Mustelin, T., Mats Jerkeman, Persson, J. L. & Gjörloff Wingren, A., 2007, In : Leukemia & Lymphoma. 48, 11, p. 2221-2232

    Research output: Contribution to journalArticle

  27. CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.

    Linderoth, J., Mats Ehinger, Mats Jerkeman, Pär-Ola Bendahl, Åkerman, M., Berglund, M., Enblad, G., Erlanson, M., Roos, G. & Cavallin-Ståhl, E., 2007, In : Leukemia & Lymphoma. 48, 9, p. 1774-1779

    Research output: Contribution to journalArticle

  28. Chronic lymphocytic leukemia with osteolytic Richter's syndrome mimicking myeloma bone disease shows no over-expression of DKK1

    LAZAREVIC, VLADIMIR., Wahlin, A., Zhan, F. & Shaughnessy, J., 2006 Sep, In : Leukemia & Lymphoma. 47, 9, p. 1987-8 2 p.

    Research output: Contribution to journalArticle

  29. Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy plus G-CSF in patients with chronic myelogenous leukemia in first chronic phase

    Olsson-Stromberg, U., Hoglund, M., Bjorkholm, M., Braide, I., Carlson, K., Gahrton, G., Grimfors, G., Hast, R., Lerner, R., Linder, O., Ljungman, P., Lofvenberg, E., Malm, C., Nilsson, P-G., Paul, C., Rodjer, S., Stenke, L., Tidefeldt, U., Turesson, I., Uden, A-M. & 6 othersWahlin, A., Vilen, L., Winqvist, I., Zettervall, O., Oberg, G. & Simonsson, B., 2006, In : Leukemia & Lymphoma. 47, 9, p. 1768-1773

    Research output: Contribution to journalArticle

  30. Letter
  31. Frequency and clinical implications of SOX11 expression in Burkitt lymphoma

    Tove Wästerlid, Nordström, L., Freiburghaus, C., Pedersen, M., Nørgaard, P., Gang, A. O., Brown, P., Michael Dictor, Mats Jerkeman & Sara Ek, 2017, In : Leukemia & Lymphoma. 58, 7, p. 1760-1763 4 p.

    Research output: Contribution to journalLetter

  32. Protein kinase C expression is deregulated in chronic lymphocytic leukemia

    Kabir, N. N., Lars Rönnstrand & Julhash U. Kazi, 2013, In : Leukemia & Lymphoma. 54, 10, p. 2288-2290

    Research output: Contribution to journalLetter

  33. Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study

    Lazarevic, V., Remberger, M., Hagglund, H., Gunnar Juliusson, Omar, H., Halbook, H., Kimby, E., Malm, C., Wahlin, A. & Johansson, J-E., 2012, In : Leukemia & Lymphoma. 53, 3, p. 503-505

    Research output: Contribution to journalLetter

  34. Clonal evolution to histiocytic sarcoma with the BCR/ABL rearrangement 14 years after acute lymphoblastic leukemia.

    Michael Dictor, Warenholt, J., Gyorgy, C., Månsson, I. & Larsson, G., 2009, In : Leukemia & Lymphoma. 50, p. 1892-1895

    Research output: Contribution to journalLetter

  35. Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma

    Berglund, M., Thunberg, U., Fridberg, M., Gjörloff Wingren, A., Gullbo, J., Leuchowius, K-J., Amini, R-M., Lagercrantz, S., Biloglav, A., Enblad, G. & Soderberg, O., 2007, In : Leukemia & Lymphoma. 48, 5, p. 1038-1041

    Research output: Contribution to journalLetter

  36. Debate/Note/Editorial
  37. The association of cancer and venous thrombosis: yes, Trousseau is right ... again!

    Kristinsson, S. Y. & Ingemar Turesson, 2011, In : Leukemia & Lymphoma. 52, 5, p. 734-735

    Research output: Contribution to journalDebate/Note/Editorial

  38. Review article
  39. Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network

    Dreyling, M., Amador, V., Callanan, M., Mats Jerkeman, Le Goui, S., Pott, C., Rule, S. & Zaja, F., 2015, In : Leukemia & Lymphoma. 56, 4, p. 866-876

    Research output: Contribution to journalReview article

  40. MyelomA Genetics International Consortium

    Morgan, G., Johnsen, H. E., Goldschmidt, H., Palumbo, A., Cavo, M., Sonneveld, P., San Miguel, J., Chim, C. S., Browne, P., Einsele, H., Waage, A., Ingemar Turesson, Spencer, A., Hajek, R., Ludwig, H., Hemminki, K. & Houlston, R., 2012, In : Leukemia & Lymphoma. 53, 5, p. 796-800

    Research output: Contribution to journalReview article